RENOWN NEWSROOM

Renown Urgent Care and Emergency Room teams encourage you to stay safe. Urgent Care is available seven days a week at 10 locations across northern Nevada and Emergency Rooms 24/7.  Millions of people across the West live in areas where air pollution can cause serious health problems. Local air quality can affect our daily lives. Like the weather, it can change from day to day. Northern Nevada Public Health’s (NNPH) Air Quality Management Division (AQMD) has issued an Air Quality Advisory due to the Davis Fire burning in southern Washoe County. Air monitors for the most region hit the “Moderate” range Saturday night, which is 151-200 on the Air Quality Index (AQI). That means some members of the public may experience health effects. All residents in impacted areas are encouraged to regularly monitor the air quality nearest them at www.airnow.gov and limit outdoor exposure when they see or smell smoke. Exposure to elevated PM2.5 (fine particulate matter in smoke) concentrations can result in eye and throat irritation, headaches, nausea, shortness of breath, congestion, coughing, impaired lung function and chest pain, especially among sensitive individuals such as the elderly, children, people with asthma, people with heart or lung conditions, pregnant women and anyone who is exercising or working hard outdoors.   Aleise Whitlock, APRN, Section Chief for Renown Urgent Care advises that there are people more likely to be affected when fine particle pollution reaches an unhealthy level, including: People with asthma or breathing conditions like Chronic Obstructive Pulmonary Disease. People who have heart disease or high blood pressure. Children and older adults. People doing extended or heavy physical activity like playing sports or working outdoors. “Everyone should take precautions when the air quality is unhealthy. Air pollution can aggravate heart and cardiovascular disease as well as lung diseases like asthma and COPD. When the air quality is unhealthy, people with these conditions may experience symptoms like chest pain, shortness of breath, wheezing, coughing, or fatigue. If you are experiencing any of these symptoms, use your inhalers as directed and contact your health care provider,” says Ms. Whitlock. “If you do not have a health care provider, we are happy to see you. Renown Urgent Care offices are on almost every corner, with providers ready to see you.” She advises to take it easy and listen to your body, and: Limit, change, or postpone your physical activity level. Drink plenty of water.  Stay away from local sources of air pollution like busy roads and wood fires. Use a damp cloth or mask to reduce smoke inhalation if you must go outside. If you have asthma or other breathing conditions like COPD keep your relief/rescue inhaler with you. People with asthma should review and follow guidance in their written asthma action plan. Make an appointment to see your health provider to be sure you have an asthma action plan. When to Visit the Emergency Department Bret Frey, MD, President, Western Emergency Physicians and Renown Health Emergency Departments, says, “Seek emergency care if you or someone you know is experiencing any of the following symptoms due to smoke exposure: Severe shortness of breath or difficulty breathing-If breathing becomes labored or painful, you cannot catch your breath even after resting, this may be a sign of serious respiratory distress. Chest pain or tightness- Any discomfort in the chest, particularly if it is associated with breathing, should be evaluated immediately.  Persistent coughing or wheezing- If a cough doesn’t improve or worsens, or if you develop wheezing, you should seek emergency medical attention.  Confusion, dizziness or fainting- These can be signs of oxygen deprivation, and immediate care is critical. Bluish lips or face- A clear indicator that oxygen levels are dangerously low and emergency medical treatment is needed.  Burns or smoke inhalation from a fire- Individuals who have been exposed to fire, or smoke in a confined space, should be evaluated for potential lung damage and other complications.  “Even just one hour of smoke exposure can affect our lungs and hearts, and these consequences can reach people far beyond the direct area endangered by the fire. Children, older adults, pregnant women, people with preexisting cardiopulmonary disease, communities of color, economically disadvantaged communities, and people with preexisting chronic health conditions like asthma, diabetes, and obesity are all especially vulnerable to the air pollution that wildfires cause," says Dr. Frey. Renown Urgent Care provides treatment for a wide range of minor injuries, illnesses and medical concerns that are urgent but not life-threatening, that require same-day medical attention and are more affordable than the emergency room at 10 convenient sites, including Reno, Sparks, Carson City, USA Parkway, Fallon and Fernley. You can walk-in or book ahead online at www.renown.org.  Emergency Care If you have an emergency, call 911. The Renown Regional Emergency Room and Renown Children’s Emergency Room, located at 1155 Mill St, Reno, NV, are equipped to handle a wide range of emergencies, and Regional is the only Level II Trauma Center between Sacramento and Salt Lake City. Renown South Meadows Emergency Room is located at 10101 Double R Blvd, Reno, NV 89521. Wait times for triage are generally less than 15 minutes and can be viewed here. The dedicated team is ready to provide immediate attention with empathy and professionalism 24 hours a day, 365 days a year.      About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Where There is Smoke; There May Be Headaches, Nausea and Coughing

Renown’s Surgical Oncology team amongst the first to use HistoSonics' image guided histotripsy system to deliver non-invasive, personalized treatments for patients with liver tumors, thanks to a private donation. Watch this video to learn more about the technology.  Renown Health announced today that the first patients have received targeted liver tumor treatments through the Edison® System histotripsy technology, which uses focused ultrasound waves to noninvasively destroy a designated tissue or tumor in the liver. This revolutionary technology represents a significant advancement in providing leading-edge surgical care to patients. Renown joins the Cleveland Clinic, Mayo Clinic and Johns Hopkins in being amongst the first in the country to offer this revolutionary non-invasive clinical procedure. Surgical oncologists Christos A. Galanopoulos MD, MBA, MSc, FACS; Nicholas Manguso, MD; and Randy Zuckerman, MD of the William N. Pennington Cancer Institute at Renown Health, are amongst the first physicians in the world trained to perform the procedure which destroys both primary and metastatic liver tumors, including those that can’t otherwise be removed surgically. Renown’s multidisciplinary team includes surgical oncologists, radiologists, oncologists and nurses who collaborate to provide comprehensive care tailored to each patient’s needs.  “At Renown Health, we are constantly investing in our clinicians, essential services, and medical innovations to help keep care local,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “We are grateful to a generous local donor, who provided us with a $1.4-million private donation to help purchase the equipment, training and to establish one of the few histotripsy programs in the U.S. at Renown. This non-invasive technology is a game changer in helping our liver surgeons and surgical oncologists to target and destroy malignant tissue in patients with either liver cancer or tumors that have spread to the liver from cancers based elsewhere in the body. This means people can now stay close to home and loved ones, and no longer need to leave Nevada for this type of advanced care.”  “As a surgeon, it’s rewarding to offer a procedure where we can precisely destroy liver tumors without using a scalpel or needles, enabling a patient’s quick recovery while avoiding certain complications common with other modalities,” says Dr. Christos Galanopoulos, Chair, Department of Surgery at Renown Health, and one of the oncology surgeons trained to perform the HistoSonics procedure. “Histotripsy uses focused ultrasound waves to mechanically destroy targeted tissue, offering a promising alternative to traditional surgical methods. This non-invasive approach reduces recovery time, minimizes complications, and improves patient outcomes. We look forward to the role this innovative technology will have in our treatment plans going forward.”  Revolutionary Technology “Histotripsy is a novel form of therapeutic ultrasound that precisely targets and liquefies tissue without damaging surrounding structures,” says Dr. Randy Zuckerman, surgical oncologist at Renown. “The system works by sending out focused ultrasound to targeted areas of tissue. The ultrasound energy creates pressure in the targeted tumor causing naturally existing gas bubbles to rapidly expand and collapse, helping break down and liquefy the targeted tissue. The entire process—from pre-treatment planning to real-time visualization—is assisted by advanced imaging technologies. We are confident that histotripsy will have a meaningful impact for patients suffering from unresectable liver disease, including liver tumors, and we are excited to share this advancement with our patients and community.”  The HistoSonics Edison® System and histotripsy procedure allows for: Precision and Accuracy: Histotripsy targets only the tumor cells, sparing adjacent healthy tissue, which is particularly advantageous in treating tumors located near critical structures.  Non-Invasiveness: As a completely non-invasive procedure, histotripsy eliminates the need for incisions, resulting in less pain and potentially faster recovery times for patients.  Reduced Risk of Complications: With no need for surgical intervention, patients face a lower risk of infection, bleeding, and other post-operative complications commonly seen in more invasive procedures. Renown’s Commitment to Innovation “The introduction of histotripsy underscores Renown Health’s dedication to staying at the forefront of medical advancements,” says Bill Plauth, MD, Chief Medical Officer for Renown Health and Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine. “By continually investing in the latest technologies and treatment modalities, we can ensure that patients receive the highest standard of care - right here in Reno.” Clinical trial results recently shared by the company showed that physicians were able to achieve a technical success rate of 95.5% in targeting and destroying malignant tissue in 44 patients with either liver cancer or tumors that had spread to the liver from cancers based elsewhere in the body.  Thanks to the Generosity of Our Community  "Through the generosity of our community, we are working to provide the best expertise, technology and programs for our patients,” said Greg Walaitis, Chief Development Officer, Renown Health Foundation. “As the only charitable, not-for-profit integrated academic healthcare organization in Reno, we appreciate that our community has helped us further our healing mission."  For more information about supporting innovative clinical care at Renown Health, visit www.renown.org/Foundation. To schedule a new patient appointment with the William N. Pennington Cancer Institute at Renown Health at 1155 Mill St in Reno, NV, call 775-982-4000. To schedule a patient for the HistoSonics procedure, call Dr. Christos Galanopoulos’ office (Renown Surgical Care) at 775-982-6270.  For media interviews, contact news@renown.org or 775-691-7308.  The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any specific disease or condition. Use of Edison System in kidney applications is limited by federal law to investigational use.     About HistoSonics HistoSonics is a privately held medical device company developing non-invasive platforms and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, and others. HistoSonics has offices in Ann Arbor, Michigan and Minneapolis, MN.  About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Groundbreaking Historic Milestone: Renown Pioneers Histosonics Edison® System Delivering Histotripsy for Non-Invasive Liver Tumor Treatment

Nurse practitioners will come to your home to discuss your needs, develop a personalized plan, and align with your team to ensure excellent health care through at-home Renown Palliative Care.  Nos complace anunciar que ahora ofrecemos servicios de interpretación en español para nuestro cuidado paliativo a domicilio. Renown Health, the only Level II Trauma Center in northern Nevada, and the leader in offering the most innovative services for critically ill adults and children is also home to a Palliative Care team dedicated to providing compassionate, specialized care for individuals and families facing the challenges of serious illness. “As Reno’s only not-for-profit health care organization we are constantly investing in better care and essential services for our community. Our goal is to keep care local, and to enhance the quality of life for patients and their families,” said Brian Erling, MD, MBA, President & CEO for Renown Health. “Empowering people with serious illnesses to receive advanced care planning in the comfort of their homes helps fuel a spirit of independence and eliminates visits to the hospital or the emergency room. This in-home Palliative Care program reflects Renown’s commitment to serving the needs of our community and ensuring patients with serious illnesses have convenient access to the clinical expertise they need, day and night.” “At Renown Health, our multidisciplinary Palliative Care team, led by physicians and nurse practitioners, work collaboratively to provide clinical support and compassionate guidance for patients with chronic and life-limiting illnesses,” says Dr. Jonathan Theriot, a specialist in Palliative Care with Renown Medical Group and a faculty member of University of Nevada, Reno School of Medicine. “We offer a consultative service that can be used at any time during a person’s illness. People can continue to see their physicians and receive treatment (such as chemotherapy or dialysis) while on service. Our nurse practitioners will come to the home to discuss the person’s individual needs and concerns and develop a personalized health care plan. We work closely with other physicians and care teams such as primary care, oncology, and home health to align and ensure the best care possible. We are available 24/7 to answer questions. Our only goal is to support the patient and their family.”  Key features of the Renown Palliative Care program include: Comprehensive Symptom Management: Focused on alleviating pain, nausea, fatigue, and other side effects and symptoms to ensure patient comfort. Emotional and Psychological Support: Provide counseling and support services to help patients and their families cope with the emotional challenges of serious illness. Spiritual Care: Offer resources and support for patients to explore spiritual concerns and a sense of well-being. Coordination of Care: Ensure seamless communications, alignment, and collaboration between healthcare clinicians on a unified care plan tailored to each patient’s needs. Support for Families: Provide education, respire care, and support services to help families navigate the complexities of caregiving for a person with a serious and life-limiting illness.  When is the time right for Palliative Care?  New diagnosis of chronic or life-limiting serious illness; Need for patient and caregiver support regarding medical decision-making; Difficult physical or emotional symptoms that impact daily life and routines; Frequent hospitalizations or Emergency Room visits; Uncertainty regarding health care options and available resources; Questions about end-of-life care; Increased difficulty completing activities of daily living. What services can Palliative Care provide? Advance care planning; Serious illness conversations; Symptom management through collaboration with your primary physician or medical provider; Reducing stress and anxiety; POLST and DNR completion; Durable medical equipment including assessment for walkers, wheelchairs, and greater mobility.  Does Insurance or Medicare/Medicaid pay for Palliative Care at home? Financial coverage for at-home palliative care services varies by provider and insurance plan. Medicare and Medicaid cover palliative care patient visits by a physician or advanced practice nurse. Some Medicare Advantage and health insurance plans offer coverage for palliative care visits and services, but specifics vary by plan. For specific guidance, contact your employer or health plan to determine coverage details and length of coverage including copays, out-of-pocket costs, and other charges for palliative care. Does Renown offer at-home Palliative Care for people who speak Spanish? "Nos complace anunciar que ahora ofrecemos servicios de interpretación en español para nuestro cuidado paliativo a domicilio," dice Monica Gonzalez-Ruesga, Community Liaison, Renown Home Health. "Estamos dedicados a brindar cuidado de alta calidad y satisfacer las necesidades lingüísticas y culturales de nuestra comunidad." Renown utiliza un servicio de interpretación telefónica en vivo para los pacientes que hablan español. Can I self-refer to the Renown Palliative Care team? Yes. Self- and physician referrals are both accepted Mon-Fri 8AM-4:30PM at 775-982-2828. More information on the Renown at-home Palliative Care program is available at renown.org/Health-Services/Palliative-and-Supportive-Care. For media interviews with Dr. Jonathan Theriot, Monica Gonzalez-Ruesga or a member of the Palliative Care team, contact news@renown.org.   About Renown Health  Renown Health is the region’s largest, locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center for adults and children, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

Read More About Serious Illness Care – Delivered Directly to Your Home by Renown Health

Wearing headphones or earbuds is a daily activity for many of us. Listening to music, podcasts, meetings, phone calls; there are endless reasons to stick them in or on your ears. However, if your ears start to feel plugged, full; or you feel dizzy, lightheaded or hear ringing in your ears; you may be experiencing ear wax build up where your ear canals become blocked and affect your hearing. If you’ve tried to clean your ears (please don’t use Q-Tips®), but still have symptoms, pain, or hearing loss, it’s time to see your physician, nurse practitioner, physician assistant or visit Renown Urgent Care. “Ear wax isn’t dirty. It’s normal,” says Ryan Bristol, APRN, Advanced Practitioner of Nursing at Renown Urgent Care. “Ears are self-cleaning miracles, and naturally clean themselves with the help of jaw movement and skin migration. However, wearing headphones or earbuds for hours blocks earwax from naturally draining from the ear. Additionally, the dirt and bacteria that these headphones often carry can cause an infection on their own, and earwax buildup can trap dirt in the ear and block the canal completely. The snug fit of headphones can create a conducive environment for the accumulation of ear wax. It's crucial for individuals to be mindful of this and take necessary precautions to prevent complications." “Individuals experiencing symptoms such as ear pain, decreased hearing, or a sensation of fullness in the ears are encouraged to seek evaluation and treatment at their nearest urgent care facility,” says Rahul Mediwala, MD, CEO of Renown Medical Group. “By addressing ear wax build-up promptly, individuals can mitigate the risk of complications and maintain optimal ear health. Fortunately, prompt, pain-free and effective treatment is available at Renown Urgent Care. We offer professional ear wax removal procedures performed by trained staff, providing relief to those experiencing discomfort or hearing impairment due to excessive ear wax build-up.” The experts at Renown Health gave us some background. What is ear wax and why is it healthy? Ear wax is a protective substance called sebum made of fat, skin cells and sweat. Ear wax is produced by glands in the ear canal. It helps protect the ear from germs and dirt and prevents the sensitive skin of the ear canal from becoming irritated. It is normal and healthy to have a thin lining of ear wax on the canal. Ear wax will sometimes accumulate and move to the outer ear canal, where it would typically fall out or be wiped away. This is also normal. When should I seek care? An ear canal has too much wax if the ear feels plugged or hearing is affected. The accumulation of wax happens very gradually, so ears do not necessarily feel waxy. The problem is usually noticed because of changes in hearing. Over the counter remedies may offer relief. However, in some cases, the earwax has built up or become impacted, and ears need to be treated. What is the treatment? At Renown Urgent Care, we offer professional ear wax removal procedures performed by trained staff, providing relief to those experiencing discomfort or hearing impairment due to excessive ear wax build-up. Wax is flushed from the ear canal using a syringe filled with warm water and saline or diluted hydrogen peroxide. Most patients find the procedure is fast, pain free and effective. How can I prevent earwax buildup from headphones and ear buds? Most people who wear headphones or use earbuds occasionally or intermittently don’t have difficulties with excessive ear wax. Wax accumulation also depends on the size of the ear canals and the productivity of the oil glands in the ear canal. You can choose to use over the ear headphones. If you prefer to use in-ear headphones, the best modes of excess ear wax prevention are to: Clean headphones and earbuds regularly with a cloth or disinfectant wipes; Avoid sharing headphones or earbuds with other people; Take breaks from headphones and earbuds so ears can breathe and get back to normal; Pay attention to your ear health. Should we talk about Q-tips? Yes! Q-tips (and similar products) are rarely helpful for managing ear wax. The cotton on the end of the Q-tip is usually unable to pull the wax out of the canal. Worse, they can push the wax deep inside the ear canal, and it can end up impacted. Where should I seek care? Individuals experiencing symptoms such as ear pain, decreased hearing, or a sensation of fullness in the ears are encouraged to seek evaluation and treatment at a medical facility. By addressing ear wax build-up promptly, individuals can mitigate the risk of complications and maintain optimal ear health. Renown Urgent Care sees patients 365 days a year for medical concerns that are urgent but not life-threatening at many locations across northern Nevada. Book ahead to reserve a time slot at one of our ten urgent care locations. If you do not see time slots that work for you, you can still go to any location that has "walk-ins available" listed. For more information, or to book an appointment, go to renown.org/Health-Services/Urgent-Care. Renown Health is the region’s locally governed, not-for-profit integrated health care network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,200 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health.

Read More About Let Those Ears Breathe! Increased Headphone and Ear Bud Use Leads to Ear Wax Build Up; Renown Urgent Cares Offer Relief

Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

Renown Health now offers urgent care services to patients with Medicaid insurance at the locations on USA Parkway, Los Altos and in Carson City.  Renown’s 10 Urgent Care locations see patients 365 days a year for medical concerns that are urgent but not life-threatening. Renown has recently expanded the number of urgent care sites accepting Medicaid insurance to include the USA Parkway, Los Altos and Carson City locations. Medicaid provides health coverage to thousands of Nevadans, including eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities. Medicaid is now accepted at six Renown Health Urgent Care locations at the following addresses: 440 NV-439 #1, USA Parkway 202 Los Altos Pkwy, Sparks 2814 N. Carson St., Ste 101, Carson City 975 Ryland St., Reno 1343 W. Newlands Dr., Fernley 560 E. Williams Ave., Fallon “As Reno’s only not-for-profit health care provider, we see all patients, regardless of their ability to pay. Increasing access to urgent care medical services remains a priority for us,” said Brian Erling, MD, MBA, Renown Health President, and CEO. “With a lack of medical providers and long wait lists for care in Washoe County, many people may not seek treatment when ill, and their conditions become more advanced, making treatment more difficult and costlier. We are working to hire additional physicians and medical providers to meet the need. We are pleased to help reduce barriers to care by accepting people with Medicaid insurance at six urgent care locations in Reno-Sparks and in our neighboring communities.” Government initiatives like Medicaid are designed to help uninsured individuals secure health care coverage. Medicaid is the largest health insurance provider in the United States, providing coverage to millions of Americans. As of July 2023, 835,888 Nevadans have enrolled in Medicaid and CHIP (Children’s Health Insurance Program). Statistics show that 21% of people in Washoe County have Medicaid coverage (2021). “We continue to seek new ways to meet the healthcare needs of everyone in our community,” said Rahul Mediwala, MD, CPE, Renown Medical Group CEO. “Our skilled providers at all Renown Urgent Care locations are able to diagnose and treat a variety of non-life-threatening illnesses, including respiratory illness; allergic reactions; minor burns, cuts and bites; sprains; urinary tract infections and more.” For life-threatening emergencies and when urgent care locations are closed, the Emergency Rooms at Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Children’s Hospital are ready to treat and care for all patients, 24/7. The current hours of operation for all Renown Health locations are available at renown.org/locations. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Three More Renown Urgent Cares Now Accepting Patients with Medicaid for a Total of Six Locations Across Northern Nevada

Gift from Jeanne and Raymond Conrad will support development of the Conrad Breast Center in the new Specialty Care Center at Renown South Meadows Medical Center. Renown Health Foundation announced a $5 million gift from local philanthropists Jeanne and Raymond Conrad on Monday, Oct 30. This gift will establish the Conrad Breast Center at the William N. Pennington Cancer Institute at Renown. The center will be housed in the Specialty Care Center at Renown South Meadows Medical Center. The three-story, 121,000 square foot Specialty Care Center being built on the Renown South Meadows Medical Center campus will feature expanded laboratory and diagnostic services, a surgery center and expanded sterile processing department and more. The Conrad Breast Center is the latest addition to the services planned for the Specialty Care Center and will include imaging, infusion and surgery services along with a wellness center. “With a service area of over 100,000 square miles that serves approximately one million people, Renown sees individuals from all walks of life,” said Jeanne Conrad, philanthropist. “My husband Raymond and I share Renown’s vision for a healthy community and establishing advanced care options for even the most difficult-to-treat cancer cases. We all have been impacted by breast cancer in some way which is why we feel honored to create this legacy.” According to the National Cancer Institute, 12.9% of women born in the United States will develop breast cancer at some time during their lives (based on 2015–2017 data). Here in Nevada, the American Cancer Society estimates 2,620 new cases of breast cancer will be diagnosed in 2023 and that 440 Nevadans will die from breast cancer this year. “Renown Health’s mission to provide best-in-class care in our northern Nevada community and beyond is only possible with generous donors like Jeanne and Raymond Conrad,” said Brian Erling, MD, MBA, Renown Health President & CEO. “This gift establishing the Conrad Breast Center within the William N. Pennington Cancer Institute will positively impact lives in our community for years to come. Cancer does not discriminate and Renown strives to create care environments that cater to all individuals. Our goal is to save lives and ensure better outcomes while keeping families together with convenient care options.” During the formal announcement of the Conrad Breast Center on Monday, Oct. 30, Renown patient and breast cancer survivor, Carolyn Dragics, spoke about her experience receiving care at Renown. Carolyn emphasized that staying close to home was a crucial part of her care journey. To continue expanding regional cancer care options and keep locals close to home, Renown Medical Group recently welcomed two distinguished breast surgical oncologists, Colleen O'Kelly-Priddy, MD and Michelle K. Chu, MD to the team. As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. “Northern Nevada’s population continues to grow, and Renown is positioning itself to have the appropriate amount of cancer care providers available for everyone who may need it,” said Greg Walaitis, Renown Health Chief Development Officer. “As the region’s largest not-for-profit healthcare system, Renown works tirelessly to provide members of our community with advanced care. This establishing donation from the Conrad family will continue to build Renown’s vision for increasing cancer care options in our region.” “Every day I am inspired by not only the patients we care for who are fighting the good fight against cancer, but also by the donors like the Conrad family who have given us the opportunity to support our patients in their fight,” said Max Coppes, MD, PhD, MBA, Renown Health’s William N. Pennington Cancer Institute Director. The Conrad Breast Center is another step towards the William N. Pennington Cancer Institute’s ultimate goal for our community: establishing an NCI-designated Cancer Center in Reno.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About $5 Million Donation to Renown Health Foundation Will Increase Access to Breast Cancer Care in Northern Nevada

Renown Medical Group is thrilled to welcome two distinguished breast surgical oncologists, Colleen O'Kelly-Priddy, MD and Michelle K. Chu, MD to the team. These highly skilled breast surgeons will solely focus on providing breast care and therefore play a pivotal role in Renown Health’s William N. Pennington Cancer Institute’s commitment to provide subspecialized care to the people living in our community and beyond. Dr. Colleen O'Kelly-Priddy is a fellowship-trained, board-certified breast surgical oncologist with an impressive background in breast cancer surgery. Dr. Priddy was born at Washoe Medical Center (which later became Renown Regional Medical Center) and grew up in Susanville, CA before attending Stanford University for her undergraduate studies. She is a graduate of the University of Nevada, Reno School of Medicine. "I am thrilled to return to Reno to help increase access to world-class surgical breast cancer care,” said Dr. Priddy. “My focus is to provide exceptional care, particularly for young people with breast cancer. I am excited to continue my mission here in northern Nevada." Dr. Michelle K. Chu, a board-certified general surgeon, brings her extensive experience in advanced breast cancer treatment to the Renown team. Dr. Chu received her undergraduate degree from the University of Pennsylvania and her medical degree from Western Reserve School of Medicine in Cleveland, OH. Dr. Chu specializes in oncoplastic breast conserving surgery and nipple sparing mastectomies. "I believe in tailoring treatment options to each patient's unique needs,” Dr. Chu said. “Whether it's preserving the natural shape of the breast or supporting the 'Going Flat' movement, our team strives to provide the best possible outcome for every patient." The newest addition to the William N. Pennington Cancer Institute, Renown Breast Surgery Care provides comprehensive breast surgery care at 1500 E. 2nd Street in Reno, adjacent to the Renown Regional Medical Center campus. "Breast cancer accounts for approximately 20% of newly diagnosed cancer cases in Washoe County, with roughly 520 new cases annually, establishing it as the most prevalent cancer type within our community,” says Brian Erling, MD, MBA, President & CEO, Renown Health. “We are proud, as the community’s largest not-for-profit healthcare system, to invest in cancer prevention and early diagnoses, including mammography screening and genetic research. For those diagnosed with breast cancer, Renown now offers two superb breast surgeons specializing in breast preservation surgery, and a breast surgery center providing comprehensive, compassionate care. Our goal is to save women’s lives, save families and ensure better care and better outcomes. This is a major step forward for women’s healthcare and our community.” As part of this expansion, Renown is assuming operations of Reno Surgical Advocates, a respected private practice in Reno. "Access to expert breast cancer care close to home is crucial, and our dedicated team at Renown Breast Surgery Care will work tirelessly to provide the highest level of care to patients while working closely with our other cancer specialists," said Max Coppes, MD, PhD, MBA, Director, William N. Pennington Institute for Cancer. “With the exceptional expertise of Dr. Colleen O'Kelly-Priddy and Dr. Michelle K. Chu, coupled with our state-of-the-art facility; Renown Health is a true partner in the fight against breast cancer in northern Nevada.” "People are increasingly relocating to northern Nevada, and in fact, Washoe County experienced a 2.1% population growth from April 2020 to July 2022. Consequently, although northern Nevada does not exhibit an above-average cancer rate, we are observing a rise in cases at our facilities," said Dr. Lee Schwartzberg, MD, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute. "Renown Health is positioned to meet this growing demand, and we take pride in consistently adding nationally renowned healthcare providers to our team to save the lives of women in northern Nevada.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Saving More Lives; Renown Expands Breast Cancer Care, Adding Two Best-In-Class Breast Surgeons

Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers. The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact. Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw. “We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.” Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology. Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1 Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant. “At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.” The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States. “Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.” Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer. For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org. Click here for more information on the Sanderson Study. About Freenome Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California. About Renown Health’s William N. Pennington Cancer Institute The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Read More About Freenome Adds Renown Health As Partner for The Sanderson Study

Recognized as one of the world’s leading breast cancer experts as a 2023 Legends in Cancer Honoree Dr. Lee Schwartzberg, FACP, Section Chief of Medical Oncology at the William N. Pennington Cancer Institute at Renown, was honored as the 2023 Legends in Cancer honoree at this year's Best of Breast conference for his contributions to the field of breast cancer. The conference took place on Jan. 21 and 22. Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 36 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates across the country, and here in Washoe County have declined progressively due to advancements in treatment, detection, and care. Each year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men. Here in Washoe County, more than 21 deaths per 100,000 females are due to breast cancer, a significant decrease since 2012 when 24 deaths per 100,000 females were reported. Dr. Schwartzberg was selected for this award based on his unique and vast contributions to advancing science and patient care, including his major research interests such as therapeutic approaches to breast cancer, targeted therapies, and supportive care. The selection committee evaluates each candidates’ body of work — including contributions to the field of breast cancer in clinical research, patient care, mentoring and community service — before deciding on an honoree. “Dr. Schwartzberg is deserving of this honor. As a national expert in the study and treatment of breast cancer, precision medicine and supportive care, Dr. Schwartzberg is transforming cancer care and improving the lives of all of us in northern Nevada. As the most preferred cancer program in the region, we are working with the support of donors like The William N. Pennington Foundation to recruit additional oncology specialists and cancer science researchers to become the first National Cancer Institute-designated comprehensive cancer care center in Nevada," said Dr. Brian Erling, MBA, CEO of Renown Health. “The incredible care that comes from the William N. Pennington Cancer Institute is possible because of nationally recognized oncologists like Dr. Schwartzberg.” “Dr. Schwartzberg completed fellowship training in medical oncology and hematology at Memorial Sloan Kettering Cancer Center in New York, where he also served as Chief Medical Resident and was a founding member of the institutional ethics committee,” add Paul J. Hauptman, MD, dean of the University of Nevada, Reno School of Medicine and chief academic officer for Renown Health. “We are proud that he serves as a professor of clinical medicine at the University of Nevada, Reno School of Medicine. His research interests include supportive care, precision medicine and patient-reported outcomes in breast cancer and he has published over 300 peer-reviewed manuscripts, book chapters and monographs.” “It is an honor to work with Dr. Schwartzberg and his patients have the most incredible things to say about the care he provides.” said Dr. Max J Coppes, PhD, MBA, Director, William N. Pennington Cancer Institute, Renown Health. “He understands that his patients are going through one of the most challenging times in their lives. Dr. Schwartzberg brings decades of experience to our community, is a great listener, and treats everyone with compassion and dignity. We are so proud to have him at Renown.” The Best of Breast Conference is an innovative medical education program that gathers the world's leading breast cancer experts to discuss cases with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care and survivorship and recurrence — all while incorporating data from the major oncologic annual meetings. Dr. Schwartzberg has been selected to chair Total Health’s spring oncology education retreat in Lake Tahoe on April 15 and 16. The event’s comprehensive agenda will allow attendees to engage with the latest research and strategies in cancer care while networking with colleagues from across the country in a peaceful setting. Additional conference information is available here. For women, breast exams using mammography after 40 years old is recommended. For those age 75 and older, a mammogram is recommended every year. Having regular mammograms can lower the risk of dying from breast cancer. Both 3-D digital mammography and whole breast ultrasounds are available at the Greenberg Breast Health Center at Renown and other locations across northern Nevada. The Affordable Care Act makes breast cancer screening and counseling free. All health plans must cover these benefits at no cost to you. Renown MyChart app users can self-schedule a mammogram appointment. To call to schedule, dial 775-982-8100. At the William N. Pennington Cancer Institute at Renown Health, patients receive innovative, personalized treatment to fight cancer while an experienced team provides the support and technology to maintain the highest quality of life. The Renown team’s clinical expertise and advanced treatment options blend evidence-based care with leading-edge research to improve cancer outcomes for every patient and family. For more information or a referral, visit renown.org/cancer. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About Total Health Total Health is a medical information company of planning experts who produce tailored content, courses, and conferences for oncology healthcare providers, virtual and in-person. Total Health believes knowledge is power. Its mission is to give oncology healthcare providers an educational experience that equips them with the latest strategies to improve clinical practice and treatment outcomes.

Read More About Dr. Lee Schwartzberg Honored With 2023 Legends in Cancer Award

Max Coppes, M.D., Ph.D., MBA who has served as Nell J. Redfield Chair of Pediatrics at the University of Nevada School of Medicine (UNR Med) and pediatrician-in-chief at Renown Children’s Hospital for the last six years has announced he is stepping down to lead Renown’s Pennington Cancer Institute on a full-time basis. Dr. Coppes will continue to serve as Professor of Pediatrics and Internal Medicine at UNR Med. “Our goal is to improve the health of Nevadans and reduce the burden of cancer,” said Thomas Graf, CEO of Renown Health. “Having Dr. Coppes as our clinical leader for the William N. Pennington Cancer Institute on a full-time basis reflects Renown and UNR Med’s commitment to increase access to cancer care, foster a deeper partnership with UNR Med on clinical trials, collaborate on cancer research opportunities, and enhance medical education and post-graduate training. We are thrilled to have Dr. Max leading this important effort.” Today’s announcement comes two weeks after the William N. Pennington Foundation announced a $15.5 million gift to the Renown Health Foundation to help establish the William N. Pennington Cancer Institute at Renown. Dr. Coppes, a pediatric oncologist by training, has experience in leading large-scale, nationally recognized academic cancer center teams in both the U.S. and Canada. Dr. Coppes came to Reno in 2014 from the British Columbia Cancer Agency in Vancouver, where he served as president with responsibility for six regional cancer centers and two cancer research centers. He was an attending physician at BC Children's Hospital and a professor of Medicine and Pediatrics at the University of British Columbia. During his career, Coppes served as senior vice president at Children's National Medical Center in Washington, D.C. and held positions at several prestigious facilities in the U.S. and Canada including The Hospital for Sick Children (SickKids) in Toronto, Georgetown University, The National Cancer Institute, and the Cleveland Clinic. Since 2016, Dr. Coppes has served in the joint leadership role as the Nell J. Redfield Chair of Pediatrics at UNR Med and pediatrician-in-chief at Renown Children's Hospital, a position made possible through generous philanthropic support from the Nell J. Redfield Foundation along with investments by Renown Health and the School of Medicine. In 2016, the Pennington Foundation recognized the need for enhanced care and expertise for pediatrics and donated $7.5 million to Renown Children’s Hospital to establish the William N. Pennington Fund for Advanced Pediatric Care. “As the Nell J. Redfield Chair of Pediatrics at the University of Nevada, Reno School of Medicine and pediatrician-in-chief at Renown Children's Hospital, Dr. Coppes blazed the trail for the integration of academic and clinical missions at UNR Med and Renown. He demonstrated visionary leadership and undoubtedly will bring the same energy and vision as the clinical leader for the William N. Pennington Cancer Institute,” said Melissa Piasecki, Acting Dean of UNR Med and Chief Academic Officer for Renown Health. “Dr. Max Coppes is an extraordinary leader. In the last six years he has done much to elevate the standard of pediatric care available in our community,” said Sy Johnson, President and Chief of Staff of Renown. “Thanks to Dr. Coppes’ leadership, the generosity of the Pennington gift and other donors, 100,000 area children now have access to pediatric specialists and contemporary healthcare services at the region’s only children’s hospital. Now, less than 3% of all pediatric patients and their families need to leave the area for specialty care. That is an incredible accomplishment.” Significant achievements made under Dr. Coppes leadership include: Advancing Renown Children’s Hospital, the only dedicated children’s hospital in northern Nevada, offering programs and services for families from a 100,000 square mile area, from Sacramento, CA to Salt Lake City, Utah. Renown Children’s provides the area’s only Children’s Emergency Room, Pediatric ICU (PICU), children’s imaging center and the largest neonatal ICU (NICU), a level III intensive care unit. Under his leadership, the following service lines were established; adolescent medicine, pediatric hematology/oncology, pediatric nephrology, pediatric infectious diseases, pediatric ophthalmology, pediatric orthopedic surgery, pediatric cleft and craniofacial surgery, pediatric urology, pediatric dentistry, and pediatric emergency medicine. Hiring and supporting a team of over 40 pediatric physician specialists. These clinicians provide 30,000 patient visits annually, offering an exceptional level of care to help families. As a testimony to the community’s confidence in the care provided, market share for pediatric services at Renown Health is now close to 90%. Renown’s membership in the Children’s Oncology Group (COG), which gives local pediatric cancer patients access to the world’s largest organization devoted exclusively to childhood cancer and most leading-edge treatments. Application to establish a 3-year accredited (by the Accreditation Council for Graduate Medical Education (ACGME) pediatric residency program in Reno. If approved in September 2022, Renown Health and UNR Med will start training four new pediatricians each year starting in July 2023. Successful application to the Nevada Governor's Office of Science, Innovation & Technology to receive financial support to fund a new Graduate Medical Education program. Renown Children’s Hospital was awarded $ 870,433 for the new pediatric residency program. New construction of an expanded Neonatal Intensive Care Unit (NICU) with increased capacity to 49 bassinets, an expanded Pediatric Intensive Care Unit (PICU) with increased capacity to 16 private patient and family rooms, and a new Renown Children's Hospital in-patient floor with increased capacity for 38 private patient and family rooms for a total capacity of 58 pediatric beds on Level 4 of Renown Regional Medical Center. In 2021, Dr. Coppes was named the Healthcare Hero Community Partner by Northern Nevada Business Magazine.

Read More About Dr. Max Coppes to Lead William N. Pennington Institute